Nirvana Life Sciences Inc. filed its Annual on Aug 29, 2022 for the period ending Apr 30, 2022. In this report its auditor, Dale Matheson Carr-Hilton, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.05 CAD | 0.00% | 0.00% | +150.00% |
1st Jan change | Capi. | |
---|---|---|
+150.00% | 1.77M | |
+36.23% | 50.93B | |
-0.15% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+12.54% | 26.02B | |
-22.24% | 18.9B | |
+7.74% | 13.21B | |
+24.67% | 12.17B | |
+29.29% | 12.16B |
- Stock Market
- Equities
- NIRV Stock
- News Nirvana Life Sciences Inc.
- Nirvana Life Sciences Inc. Auditor Raises 'Going Concern' Doubt